Aghajan Y, Malicki DM, Levy ML, Crawford JR (2019) Atypical central neurocytoma with novel EWSR1-ATF1 fusion and MUTYH mutation detected by next-generation sequencing. BMJ Case Rep. https://doi.org/10.1136/bcr-2018-226455

Article  PubMed  PubMed Central  Google Scholar 

Bale TA (2020) FGFR- gene family alterations in low-grade neuroepithelial tumors. Acta Neuropathol Commun 8:21. https://doi.org/10.1186/s40478-020-00898-6

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bonney PA, Boettcher LB, Krysiak RS 3rd, Fung KM, Sughrue ME (2015) Histology and molecular aspects of central neurocytoma. Neurosurg Clin N Am 26:21–29. https://doi.org/10.1016/j.nec.2014.09.001

Article  PubMed  Google Scholar 

Chioni AM, Grose RP (2021) Biological significance and targeting of the FGFR axis in cancer. Cancers (Basel). https://doi.org/10.3390/cancers13225681

Article  PubMed  Google Scholar 

Donoho D, Zada G (2015) Imaging of central neurocytomas. Neurosurg Clin N Am 26:11–19. https://doi.org/10.1016/j.nec.2014.09.012

Article  PubMed  Google Scholar 

Hassoun J, Gambarelli D, Grisoli F, Pellet W, Salamon G, Pellissier JF, Toga M (1982) Central neurocytoma. An electron-microscopic study of two cases. Acta Neuropathol 56:151–156. https://doi.org/10.1007/BF00690587

Article  CAS  PubMed  Google Scholar 

Huang S, Liu X, Zhu J, Sun Z, Chen Y, Yu H (2022) MR finding of extraventricular neurocytoma. J Coll Physicians Surg Pak 32:1478–1482. https://doi.org/10.29271/jcpsp.2022.11.1478

Article  PubMed  Google Scholar 

Kalawi AZ, Malicki DM, Abdullaev Z, Pratt DW, Quezado M, Aldape K, Elster JD, Paul MR, Khanna PC, Levy ML, Crawford JR (2022) The role of methylation profiling in histologically diagnosed neurocytoma: a case series. J Neurooncol 159:725–733. https://doi.org/10.1007/s11060-022-04117-1

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kane AJ, Sughrue ME, Rutkowski MJ, Aranda D, Mills SA, Lehil M, Fang S, Parsa AT (2012) Atypia predicting prognosis for intracranial extraventricular neurocytomas. J Neurosurg 116:349–354. https://doi.org/10.3171/2011.9.JNS10783

Article  PubMed  Google Scholar 

Le Rhun E, Preusser M, Roth P, Reardon DA, van den Bent M, Wen P, Reifenberger G, Weller M (2019) Molecular targeted therapy of glioblastoma. Cancer Treat Rev 80:101896. https://doi.org/10.1016/j.ctrv.2019.101896

Article  CAS  PubMed  Google Scholar 

Lee SJ, Bui TT, Chen CH, Lagman C, Chung LK, Sidhu S, Seo DJ, Yong WH, Siegal TL, Kim M, Yang I (2016) Central neurocytoma: a review of clinical management and histopathologic features. Brain Tumor Res Treat 4:49–57. https://doi.org/10.14791/btrt.2016.4.2.49

Article  PubMed  PubMed Central  Google Scholar 

Mahavadi AK, Patel PM, Kuchakulla M, Shah AH, Eichberg D, Luther EM, Komotar RJ, Ivan ME (2020) Central neurocytoma treatment modalities: a systematic review assessing the outcomes of combined maximal safe resection and radiotherapy with gross total resection. World Neurosurg 137:e176–e182. https://doi.org/10.1016/j.wneu.2020.01.114

Article  PubMed  Google Scholar 

Meric-Bernstam F, Bahleda R, Hierro C, Sanson M, Bridgewater J, Arkenau HT, Tran B, Kelley RK, Park JO, Javle M, He Y, Benhadji KA, Goyal L (2022) Futibatinib, an irreversible FGFR1-4 inhibitor, in patients with advanced solid tumors harboring FGF/FGFR aberrations: a phase I dose-expansion study. Cancer Discov 12:402–415. https://doi.org/10.1158/2159-8290.CD-21-0697

Article  CAS  PubMed  Google Scholar 

Oya S, Takayanagi S, Takami H, Indo M, Yamashita T, Saito N, Matsui T (2021) Masked malignant phenotype with a benign appearance: beat-up copy number profile may be the key for hemangioblastoma dissemination. Brain Tumor Pathol 38:71–77. https://doi.org/10.1007/s10014-020-00387-7

Article  CAS  PubMed  Google Scholar 

Patel DM, Schmidt RF, Liu JK (2013) Update on the diagnosis, pathogenesis, and treatment strategies for central neurocytoma. J Clin Neurosci 20:1193–1199. https://doi.org/10.1016/j.jocn.2013.01.001

Article  PubMed  Google Scholar 

Ramsahye H, He H, Feng X, Li S, Xiong J (2013) Central neurocytoma: radiological and clinico-pathological findings in 18 patients and one additional MRS case. J Neuroradiol 40:101–111. https://doi.org/10.1016/j.neurad.2012.05.007

Article  PubMed  Google Scholar 

Satomi K, Takami H, Fukushima S, Yamashita S, Matsushita Y, Nakazato Y, Suzuki T, Tanaka S, Mukasa A, Saito N, Kanamori M, Kumabe T, Tominaga T, Kobayashi K, Nagane M, Iuchi T, Yoshimoto K, Tamura K, Maehara T, Sakai K, Sugiyama K, Yokogami K, Takeshima H, Nonaka M, Asai A, Ushijima T, Matsutani M, Nishikawa R, Ichimura K (2022) 12p gain is predominantly observed in non-germinomatous germ cell tumors and identifies an unfavorable subgroup of central nervous system germ cell tumors. Neuro Oncol 24:834–846. https://doi.org/10.1093/neuonc/noab246

Article  CAS  PubMed  Google Scholar 

Schmidt MH, Gottfried ON, von Koch CS, Chang SM, McDermott MW (2004) Central neurocytoma: a review. J Neurooncol 66:377–384. https://doi.org/10.1023/b:neon.0000014541.87329.3b

Article  PubMed  Google Scholar 

Sievers P, Stichel D, Schrimpf D, Sahm F, Koelsche C, Reuss DE, Wefers AK, Reinhardt A, Huang K, Ebrahimi A, Hou Y, Pajtler KW, Pfister SM, Hasselblatt M, Stummer W, Schick U, Hartmann C, Hagel C, Staszewski O, Reifenberger G, Beschorner R, Coras R, Keyvani K, Kohlhof P, Diomedi-Camassei F, Herold-Mende C, Giangaspero F, Rushing E, Giannini C, Korshunov A, Jones DTW, von Deimling A (2018) FGFR1:TACC1 fusion is a frequent event in molecularly defined extraventricular neurocytoma. Acta Neuropathol 136:293–302. https://doi.org/10.1007/s00401-018-1882-3

Article  CAS  PubMed  Google Scholar 

Syed YY (2022) Futibatinib: first approval. Drugs. https://doi.org/10.1007/s40265-022-01806-z

Article  PubMed  PubMed Central  Google Scholar 

Takami H, Elzawahry A, Mamatjan Y, Fukushima S, Fukuoka K, Suzuki T, Yanagisawa T, Matsushita Y, Nakamura T, Satomi K, Tanaka S, Mukasa A, Saito N, Kanamori M, Kumabe T, Tominaga T, Kobayashi K, Nagane M, Iuchi T, Tamura K, Maehara T, Sugiyama K, Yoshimoto K, Sakai K, Nonaka M, Asai A, Yokogami K, Takeshima H, Narita Y, Shibui S, Nakazato Y, Hama N, Totoki Y, Kato M, Shibata T, Nishikawa R, Matsutani M, Ichimura K (2022) Transcriptome and methylome analysis of CNS germ cell tumor finds its cell-of-origin in embryogenesis and reveals shared similarities with testicular counterparts. Neuro Oncol 24:1246–1258. https://doi.org/10.1093/neuonc/noac021

Article  CAS  PubMed  PubMed Central  Google Scholar 

von Deimling A, Kleihues P, Saremaslani P, Yasargil MG, Spoerri O, Sudhof TC, Wiestler OD (1991) Histogenesis and differentiation potential of central neurocytomas. Lab Invest 64:585–591

Google Scholar